Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-13-364248
Filing Date
2013-09-11
Accepted
2013-09-11 17:19:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 d596548d424b3.htm 424B3 577376
2 GRAPHIC g596548g24c16.jpg GRAPHIC 22503
3 GRAPHIC g596548g44p91.jpg GRAPHIC 113708
4 GRAPHIC g596548g58d11.jpg GRAPHIC 391682
5 GRAPHIC g596548g61g20.jpg GRAPHIC 15204
6 GRAPHIC g596548g84k23.jpg GRAPHIC 243573
7 GRAPHIC g596548g95c29.jpg GRAPHIC 397260
  Complete submission text file 0001193125-13-364248.txt   2210601
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B3 | Act: 33 | File No.: 333-185645 | Film No.: 131091646
SIC: 2834 Pharmaceutical Preparations